| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 84, 601-608, Copyright © 1982 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
A Faichney, KG Davidson, DJ Wheatley, JF Davidson and ID Walker
The effects of prostacyclin (PGI2) on postoperative blood loss and on the
deposits which are known to form on filters in the bypass circuit were
studied in patients undergoing operations with cardioopulmonary bypass. In
this double-blind, randomized study, PGI2 or a placebo solution was
administered to 56 patients undergoing elective cardiac operations. At the
end of cardipulmonary bypass, the arterial line filter was removed from the
circuit and blood losses were accurately recorded. There was no
statistically significant difference in either the amount or the pattern of
postbypass bleeding between the PGI2 and the control patients. However, the
changes in weight of the arterial line filters and their electron
microscopic appearances suggest that PGI2 can reduce the deposition of
platelets and fibrin on the filter mesh, and in this role it may be of
value in reducing visceral injury during cardiac operations.
ARTICLES
Prostacyclin in cardiopulmonary bypass operations
This article has been cited by other articles:
|
|
 |
|
  H. A. Hennein Inflammation After Cardiopulmonary Bypass: Therapy for the Postpump Syndrome Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 236 - 255. [Abstract] [PDF]
|
|
|
|
|
|
E. Appachi and E. B. Mossad Inflammatory Mediators and S-100{beta} Protein Concentrations in Neonates and Infants With Congenital Heart Disease Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 256 - 261. [Abstract] [PDF]
|
|
|
|
 |
|
 C. I. Blauth Macroemboli and microemboli during cardiopulmonary bypass Ann. Thorac. Surg., May 1, 1995; 59(5): 1300 - 1303. [Abstract] [PDF]
|
|
|
|
|
|
H. P. Singh, E. T. Coleman, M. Hargrove, S. E. Barrow, M. B. Murphy, and T. Aherne Prostacyclin and thromboxane levels in pleural space fluid during cardiopulmonary bypass Ann. Thorac. Surg., March 1, 1995; 59(3): 647 - 650. [Abstract] [PDF]
|
|
|
|
 |
|
 J. M. Courtney, S. Sundaram, B. M. Matata, J. D. S. Gaylor, and C. D. Forbes Biomaterials in cardiopulmonary bypass Perfusion, January 1, 1994; 9(1): 3 - 10. [PDF]
|
|
|
|
|
|
I. Th. Fessatidis, J.J. Brannan, K.M. Taylor, M. Kanellaki-Kyparissi, A.K. Abdulla, and E.C.J. Olsen Effect of prostacyclin PGl2 on cardiopulmonary bypass- induced lung injury Perfusion, January 1, 1994; 9(1): 23 - 33. [Abstract] [PDF]
|
|
|
|
|
|
H. Matsuda, Y. Sawa, S. Kuki, F. Nomura, M. Ohtani, H. Takami, R. Shirakura, S. Nakano, and Y. Kawashima Evaluation of prostacyclin analogue OP-41483 as an adjunct to crystalloid cardioplegia in infants and children Ann. Thorac. Surg., August 1, 1989; 48(2): 242 - 246. [Abstract] [PDF]
|
|
|
|
|
|
T. Spyt, D. Wheatley, I. Walker, J. Davidson, K. MacArthur, and W. Martin Placebo-controlled study of Iloprost (ZK 36374) in cardiopulmonary bypass surgery Perfusion, July 1, 1988; 3(3): 179 - 186. [Abstract] [PDF]
|
|
|
|
|
|
L. Marshall Filtration in cardiopulmonary bypass: past, present and future Perfusion, April 1, 1988; 3(2): 135 - 147. [PDF]
|
|
|
|
|
|
V. J. DiSesa, W. Huval, S. Lelcuk, R. Jonas, R. Maddi, S. Lee-Son, R. J. Shemin, J. J. Collins Jr., H. B. Hechtman, and L. H. Cohn Disadvantages of Prostacyclin Infusion During Cardiopulmonary Bypass: A Double-Blind Study of 50 Patients Having Coronary Revascularization Ann. Thorac. Surg., November 1, 1984; 38(5): 514 - 519. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
